Form 4: Cadre Holdings CEO Kanders Awarded Equity

Cadre Holdings' CEO and Chairman, Warren B. Kanders, was granted 44,684 restricted stock units and options to purchase 144,735 shares of common stock.

Summary

• Warren B. Kanders, CEO and Chairman of Cadre Holdings, Inc., was granted equity awards on March 30, 2026.
• The awards include 44,684 Restricted Stock Units (RSUs) and options to purchase 144,735 shares of common stock.
• The RSUs will vest in three annual installments: 14,896 shares on March 30, 2027, and 14,894 shares on each of March 30, 2028, and March 30, 2029.
• The stock options have an exercise price of $29.39 and will vest in three annual installments of 48,245 shares each on March 30, 2027, March 30, 2028, and March 30, 2029, with an expiration date of March 30, 2036.
• These grants were made under the company's 2021 Stock Incentive Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices designed to align management incentives with long-term shareholder value, without indicating any immediate operational or financial changes.

Positives

• The equity awards align management's interests with long-term shareholder value through multi-year vesting schedules.
• The grant of stock options with an exercise price of $29.39 provides an incentive for the CEO to increase the company's stock price above this level.

Negatives

• Potential for future dilution from the issuance of new shares upon vesting of RSUs and exercise of options, which is standard for equity compensation.

Risks

• Potential for future stock price volatility impacting the value of the granted equity awards.
• Risk of forfeiture of unvested awards if employment terms are not met.

Future Outlook

The equity grants, with their multi-year vesting schedules extending to 2029 and option expiration in 2036, indicate a long-term commitment to the company's performance and growth by its CEO and Chairman.

Industry Context

StockSavvy.ai notes that executive equity compensation, such as RSUs and stock options, is a standard practice across industries, particularly in publicly traded companies, to incentivize long-term performance and align executive interests with shareholders. The size of the grant for a CEO and Chairman of a company like Cadre Holdings (a provider of safety and survivability products) is generally benchmarked against peer companies in the defense, public safety, and industrial sectors.

Comparison to Industry Standards

• The use of both Restricted Stock Units (RSUs) and stock options is a common hybrid approach in executive compensation packages, similar to practices at companies like Axon Enterprise (AXON) or MSA Safety (MSA), which also operate in related safety and security markets.
• The multi-year vesting schedule (3 years for RSUs and options) is standard for executive retention and performance incentives, aligning with best practices seen in companies across various sectors, including technology and manufacturing.
• The exercise price of $29.39 for the options, being the market price at the time of grant, is typical for "at-the-money" options, designed to reward future stock price appreciation.

Corporate Governance

Related Party Transactions

• The transaction involves an equity grant to Warren B. Kanders, the CEO and Chairman, who is a related party, as part of his compensation package.

Stakeholder Impact

• Shareholders: Potential for long-term value creation if the equity incentives motivate strong company performance; minor dilution from future share issuance upon vesting/exercise.
• Employees: May signal stability in executive leadership and a commitment to long-term growth.

Next Steps

• The granted Restricted Stock Units will begin vesting on March 30, 2027, with subsequent vesting dates on March 30, 2028, and March 30, 2029.
• The granted Stock Options will become exercisable on March 30, 2027, March 30, 2028, and March 30, 2029, and will expire on March 30, 2036.

Key Dates

Recommendation

This Form 4 filing reports a routine equity compensation grant to the CEO and Chairman, which is an expected event and does not provide new information that would fundamentally alter the company's valuation or outlook. While it aligns executive incentives with shareholder interests, it's not a catalyst for a "buy" or "sell" recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Cadre Holdings, CDRE, Warren B. Kanders, Form 4, Restricted Stock Units, Stock Options, Equity Compensation, Insider Transaction, Executive Compensation, Stock Incentive Plan